Medication Approaches for Patients With Opioid Use Disorders: Differences Between Primary Care Clinics and Specialty Addiction Treatment Programs.

Objectives: Efforts to increase access to highly effective medications for opioid use disorder (MOUD) have largely focused on primary care. Ironically, many specialty addiction treatment programs have yet to adopt MOUD. To bring MOUD access to scale, researchers need to better understand medication...

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of Addiction Medicine Vol. 20; no. 4; pp. 400 - 409
Autores principales: Franz, Berkeley, Ford II, James H., Cheng, Hannah, Garneau, Hélène Chokron, Mount, Kimberley, McGovern, Mark P.
Formato: research tables/charts Journal Article
Publicado: Lippincott Williams & Wilkins Jul2026
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=195928492&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 195928492
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        19320620
        3BL0
      jtl: Journal of Addiction Medicine
      issn: 19320620
      maglogo: N
    pubinfo:
      dt: Jul2026
      vid: 20
      iid: 4
      pid: 433
      pub: Lippincott Williams & Wilkins
      place: Baltimore, Maryland
    artinfo:
      ui:
        195928492
        195928492
        195928492
        10.1097/ADM.0000000000001556
        195928492
      ppf: 400
      ppct: 9
      formats:
      tig:
        atl: Medication Approaches for Patients With Opioid Use Disorders: Differences Between Primary Care Clinics and Specialty Addiction Treatment Programs.
      aug:
        au:
          Franz, Berkeley
          Ford II, James H.
          Cheng, Hannah
          Garneau, Hélène Chokron
          Mount, Kimberley
          McGovern, Mark P.
      sug:
        subj:
          Narcotics
          Substance Use Disorders Drug Therapy
          Substance Use Disorders Drug Therapy
          Primary Health Care
          Secondary Health Care
          Drug Rehabilitation Programs
          Buprenorphine Therapeutic Use
          Prescribing Patterns Evaluation
          Implementation Science
          Human
          Funding Source
          California
          Health Services Accessibility
          Practice Guidelines
          Guideline Adherence
          Descriptive Statistics
          Bivariate Statistics
          Comparative Studies
          Organizational Culture
          Program Implementation
          Opiate Overdose
          Unemployment
          Health Labor Supply
          Prescriptions, Drug
          Geographic Factors
          Cross Sectional Studies
          Multicenter Studies
          Washington
      ab: Objectives: Efforts to increase access to highly effective medications for opioid use disorder (MOUD) have largely focused on primary care. Ironically, many specialty addiction treatment programs have yet to adopt MOUD. To bring MOUD access to scale, researchers need to better understand medication practices across these 2 major portals of care for patients with opioid use disorder (OUD). In this study, our team examined baseline prescribing data from 62 primary care clinics and specialty addiction treatment programs (SATPs) participating in MOUD implementation endeavors across 2 states. Methods: Our primary outcomes included MOUD prescribing practices, measured by the integrating medications for addiction treatment (IMAT), which includes 7 dimensions of guideline-adherent delivery of MOUD, and an additional subscale on low threshold care. We also measured reach of MOUD to patients and adoption as the number of current MOUD prescribers. Secondary outcomes included community characteristics surrounding each type of organization. Descriptive statistics and bivariate tests explored differences between primary and specialty care settings. Results: SATPs had lower MOUD capacity and implementation as compared with primary care clinics. Specialty settings also had lower organizational support for low threshold prescribing. SATPs were located in counties with higher overdose rates, higher unemployment, fewer MOUD prescribers, and with more opioid prescriptions per capita. Conclusions: SATPs have lower MOUD implementation capacity than their primary care counterparts and are more likely to be in counties with greater OUD-related needs, economic distress, and fewer treatment resources. Selecting more precise implementation support strategies for SATPs that are late adopters of MOUD is a major need.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N